Enterome raises EUR 5M in series A

Enterome Bioscience (Paris, France) raised EUR 5 million ($6.6 million) in a series A round co-led by Seventure Partners and Lundbeckfond Ventures. Enterome is developing therapeutics and diagnostics for non-alcoholic fatty liver disease (NAFLD) and inflammatory bowel disease (IBD). ...